adjuvant-treatment

Documents about adjuvant-treatment

• Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma#837285ClinicalTrials.gov
• A Study of Adjuvant Melanoma Stakeholder Treatment Preferences#1138550ClinicalTrials.gov
• Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation#1058386ClinicalTrials.gov
• Adjuvant Aspirin Treatment for Colon Cancer Patients#1103088ClinicalTrials.gov
• Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy#1183730ClinicalTrials.gov
• Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment#1246785ClinicalTrials.gov
• Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)#1411137ClinicalTrials.gov
• Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities#1429453ClinicalTrials.gov
• Efficacy of Adjuvant Mitotane Treatment (ADIUVO)#980170ClinicalTrials.gov
• QOL After SURGERY and ADJUVANT Treatment#1086171ClinicalTrials.gov
• Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer#1364561ClinicalTrials.gov
• Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC#825545ClinicalTrials.gov
• Postoperative Adjuvant TACE Treatment in CK18 Positive Patients#861973ClinicalTrials.gov
• Propranolol Adjuvant Treatment of Bladder Cancer#640455ClinicalTrials.gov
• UVX as an Adjuvant in the Treatment of Fungal Keratitis#1408366ClinicalTrials.gov
• Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer#1444939ClinicalTrials.gov
• Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)#865996ClinicalTrials.gov
• Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer#1419158ClinicalTrials.gov
• ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment#1029951ClinicalTrials.gov
• Optimising oncologic outcomes in pT3 glottic cancers treated by transoral laser microsurgery: the impact of adjuvant treatment#211204IRIS
• MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC#1149980ClinicalTrials.gov
• Breast Cancer Registry Platform#1420873ClinicalTrials.gov
• Nigella Sativa as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia#898323ClinicalTrials.gov
• Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC#332744ClinicalTrials.gov
• Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole#1453115ClinicalTrials.gov
• Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer#1476394ClinicalTrials.gov
• Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)#303667ClinicalTrials.gov
• Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study#14287HAL (France)
• Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery#898309ClinicalTrials.gov
• Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma#280642IRIS
• Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer#1280559ClinicalTrials.gov
• Adjuvant chemotherapy for gastric cancer in elderly patients has same benefits as in younger patients#955256Koc University Digital Collections
• Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab#1454108ClinicalTrials.gov
• Effect of Meal Timing During Adjuvant Treatment for Cancer#467566ClinicalTrials.gov
• Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults#1047802ClinicalTrials.gov
• Mebendazole as Adjuvant Treatment for Colon Cancer#1337004ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）#1410566ClinicalTrials.gov
• Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)#1372599ClinicalTrials.gov
• Probiotics as Adjuvant Treatment for Bacterial Vaginosis#968223ClinicalTrials.gov
• CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER#801163ClinicalTrials.gov
• MRD in PAAD Adjuvant Therapy#859119ClinicalTrials.gov
• Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma#903961ClinicalTrials.gov
• New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy#1184782ClinicalTrials.gov
• Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer#830215ClinicalTrials.gov
• Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma#888630ClinicalTrials.gov
• Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)#1126442ClinicalTrials.gov
• Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment#160343ClinicalTrials.gov
• Study of Tinostamustine for Adjuvant Treatment of Glioblastoma#994628ClinicalTrials.gov
• Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes#867470ClinicalTrials.gov
• Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer#1340663ClinicalTrials.gov